{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:58:18Z","timestamp":1791093498583,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.surg.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T09:47:18Z","timestamp":1363168038000},"page":"779-786","source":"Crossref","is-referenced-by-count":114,"title":["Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma"],"prefix":"10.1016","volume":"153","author":[{"suffix":"Jr.","given":"H. Richard","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Royal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marybeth S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keli","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Beresneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2013.01.001_bib1","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0169-5002(07)70138-1","article-title":"Gene expression profiling of malignant peritoneal mesothelioma identifies novel targets for therapeutic intervention","volume":"54","author":"Varghese","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.surg.2013.01.001_bib2","first-page":"107","article-title":"Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End\u00a0Results Program data for 1973 through 2003","volume":"159","author":"Price","year":"2004","journal-title":"Am\u00a0J\u00a0Epidemiol"},{"key":"10.1016\/j.surg.2013.01.001_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.surg.2013.01.001_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.surg.2013.01.001_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","article-title":"Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma","volume":"70","author":"Eltabbakh","year":"1999","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6004\/jnccn.2012.0008","article-title":"Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma","volume":"10","author":"Turner","year":"2012","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.surg.2013.01.001_bib7","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","article-title":"Comprehensive management of diffuse malignant peritoneal mesothelioma","volume":"32","author":"Sugarbaker","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","article-title":"Prospective trial for the treatment of malignant peritoneal mesothelioma","volume":"67","author":"Loggie","year":"2001","journal-title":"Am Surg"},{"key":"10.1016\/j.surg.2013.01.001_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1245\/ASO.2006.05.041","article-title":"Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study","volume":"13","author":"Brigand","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib11","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib12","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1245\/s10434-010-1080-6","article-title":"Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin","volume":"17","author":"Blackham","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib13","series-title":"Current clinical oncology: regional chemotherapy: clinical research and practice","first-page":"127","article-title":"National Cancer Institute experience with regional therapy for unresectable primary and metastatic cancer of the liver or peritoneal cavity","author":"Alexander","year":"2000"},{"key":"10.1016\/j.surg.2013.01.001_bib14","first-page":"343","article-title":"Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma","volume":"134","author":"Alexander","year":"2007","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.surg.2013.01.001_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1251::AID-CNCR27>3.0.CO;2-3","article-title":"A\u00a0phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis","volume":"83","author":"Bartlett","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2013.01.001_bib17","series-title":"Peritoneal carcinomatosis: drugs and diseases","first-page":"41","article-title":"Treatment of peritoneal carcinomatosis by continuous hyperthermic peritoneal perfusion with cisplatin","author":"Alexander","year":"1996"},{"key":"10.1016\/j.surg.2013.01.001_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","article-title":"Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion","volume":"13","author":"Deraco","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","article-title":"A\u00a0review of peritoneal mesothelioma at the Washington Cancer Institute","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.surg.2013.01.001_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1477-7819-8-88","article-title":"Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma","volume":"8","author":"Foster","year":"2010","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.surg.2013.01.001_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.25555","article-title":"Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma","volume":"117","author":"Varghese","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2013.01.001_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/1097-0142(196001\/02)13:1<127::AID-CNCR2820130124>3.0.CO;2-6","article-title":"Malignant peritoneal mesotheliomas: a clinicopathological analysis of 12 fatal cases","volume":"13","author":"Winslow","year":"1960","journal-title":"Cancer"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606013000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606013000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T03:14:00Z","timestamp":1688094840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606013000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0039606013000020"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2013.01.001","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}